AAAAAA

   
Results: 1-12 |
Results: 12

Authors: MADAN SK LEE PJ VALDIVIESO M SARKAR FH
Citation: Sk. Madan et al., SIGNIFICANCE OF P53, BCL-2 AND P21(WAF-1) (P21) EXPRESSION IN LUNG-CARCINOMA, Laboratory investigation, 74(1), 1996, pp. 935-935

Authors: YADRANDJI S VISSCHER DW MADAN SK VALDIVIESO M SARKAR FH
Citation: S. Yadrandji et al., MUTATION OF K-RAS AND P53 IN PULMONARY ADENOCARCINOMA - HISTOLOGIC CORRELATIONS, Laboratory investigation, 74(1), 1996, pp. 961-961

Authors: POPLIN EA JACOBSON J HERSKOVIC A PANELLA TJ VALDIVIESO M HUTCHINS LF MACDONALD JS
Citation: Ea. Poplin et al., EVALUATION OF MULTIMODALITY TREATMENT OF LOCOREGIONAL ESOPHAGEAL-CARCINOMA BY SOUTHWEST-ONCOLOGY-GROUP-9060, Cancer, 78(9), 1996, pp. 1851-1856

Authors: VARTERASIAN M EILENDER D MOHAMMAD R CHEN B HULBURD K RODRIGUEZ D PLUDA J VALDIVIESO M ALKATIB A
Citation: M. Varterasian et al., PHASE-I TRIAL OF BRYOSTATIN-1 IN RELAPSED LYMPHOMA AND CLL, Blood, 88(10), 1996, pp. 2269-2269

Authors: LORUSSO P FOSTER BJ POPLIN E MCCORMICK J KRAUT M FLAHERTY L HEILBRUN LK VALDIVIESO M BAKER L
Citation: P. Lorusso et al., PHASE-I CLINICAL-TRIAL OF PYRAZOLOACRIDINE NSC366140 (PD115934), Clinical cancer research, 1(12), 1995, pp. 1487-1493

Authors: SARKAR FH VALDIVIESO M BORDERS J YAO KL RAVAL MMT MADAN SK SREEPATHI P SHIMOYAMA R STEIGER Z VISSCHER DW CRISSMAN JD
Citation: Fh. Sarkar et al., A UNIVERSAL METHOD FOR THE MUTATIONAL ANALYSIS OF K-RAS AND P53 GENE IN NON-SMALL-CELL LUNG-CANCER USING FORMALIN-FIXED PARAFFIN-EMBEDDED TISSUE, Diagnostic molecular pathology, 4(4), 1995, pp. 266-273

Authors: LORUSSO PM LOMEN PL REDMAN BG POPLIN E BANDER JJ VALDIVIESO M
Citation: Pm. Lorusso et al., PHASE-I STUDY OF MONOCLONAL-ANTIBODY RICIN-A CHAIN IMMUNOCONJUGATE XOMAZYME-791 IN PATIENTS WITH METASTATIC COLON-CANCER, American journal of clinical oncology, 18(4), 1995, pp. 307-312

Authors: FOSTER BJ LORUSSO PM POPLIN E ZALUPSKI M VALDIVIESO M WOZNIAK A FLAHERTY L KASUNIC DA EARHART RH BAKER LH
Citation: Bj. Foster et al., PHASE-I TRIAL OF ADOZELESIN USING THE TREATMENT SCHEDULE OF DAILY X 5EVERY 3 WEEKS, Investigational new drugs, 13(4), 1995, pp. 321-326

Authors: SARKAR FH VISSCHER DW RAVAL M MADAN S TABACZKA P WOZNIAK A KRAUT M STEIGER Z VALDIVIESO M
Citation: Fh. Sarkar et al., IMMUNOHISTOCHEMICAL EVALUATION OF CATHEPSIN-D AND CATHEPSIN-B IN NONSMALL CELL LUNG-CANCER, Laboratory investigation, 72(1), 1995, pp. 153-153

Authors: SCHEDING S MEDIA JE KRAUT M VALDIVIESO M NAKEFF A
Citation: S. Scheding et al., EFFECTS OF RHG-CSF, 5-FLUOROURACIL AND EXTRAMEDULLARY IRRADIATION ON MURINE MEGAKARYOCYTOPOIESIS IN-VIVO, British Journal of Haematology, 88(4), 1994, pp. 699-705

Authors: SCHEDING S MEDIA JE KRAUT M VALDIVIESO M NAKEFF A
Citation: S. Scheding et al., IN-VIVO EFFECTS OF COMBINATIONS OF RHG-CSF, 5-FLUOROURACIL, AND EXTRAMEDULLARY IRRADIATION ON MURINE MEGAKARYOCYTOPOIESIS, Experimental hematology, 21(8), 1993, pp. 1168-1168

Authors: FLAHERTY LE ROBINSON W REDMAN BG GONZALEZ R MARTINO S KRAUT M VALDIVIESO M RUDOLPH AR
Citation: Le. Flaherty et al., A PHASE-II STUDY OF DACARBAZINE AND CISPLATIN IN COMBINATION WITH OUTPATIENT ADMINISTERED INTERLEUKIN-2 IN METASTATIC MALIGNANT-MELANOMA, Cancer, 71(11), 1993, pp. 3520-3525
Risultati: 1-12 |